| Basics |
STAAR Surgical Company
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.
|
| IPO Date: |
March 2, 1992 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$937.03M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.56 | 2.47%
|
| Avg Daily Range (30 D): |
$0.41 | 2.26%
|
| Avg Daily Range (90 D): |
$0.53 | 2.93%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.26M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
.86M |
| Trade Size |
| Avg Trade Size (Sh.): |
79 |
| Avg Trade Size (Sh.) (30 D): |
51 |
| Avg Trade Size (Sh.) (90 D): |
60 |
| Institutional Trades |
| Total Inst.Trades: |
3,311 |
| Avg Inst. Trade: |
$2.82M |
| Avg Inst. Trade (30 D): |
$2.26M |
| Avg Inst. Trade (90 D): |
$2.18M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.42M |
| Avg Closing Trade (30 D): |
$2.37M |
| Avg Closing Trade (90 D): |
$2.42M |
| Avg Closing Volume: |
66.73K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-1.45
|
$-1.1
|
$-.7
|
|
Diluted EPS
|
$-1.44
|
$-1.1
|
$-.69
|
|
Revenue
|
$ 279.13M
|
$ 42.59M
|
$ 48.95M
|
|
Gross Profit
|
$ 206.55M
|
$ 28.01M
|
$ 31.65M
|
|
Net Income / Loss
|
$ -71.08M
|
$ -54.21M
|
$ -34.23M
|
|
Operating Income / Loss
|
$ -67.73M
|
$ -57.4M
|
$ -27.91M
|
|
Cost of Revenue
|
$ 72.58M
|
$ 14.58M
|
$ 17.3M
|
|
Net Cash Flow
|
$ -50.91M
|
$ 28.96M
|
$ -19.84M
|
|
PE Ratio
|
|
|
|
|
